Home

Steven D Rubin

CIK 1381874 · Executive VP-Administration · last filed 2026-08-07

Steven D Rubin is an Executive VP-Administration who has filed 143 SEC Form 4 insider transactions across 14 companies since 2007. The most recent filing, for ENTX, was dated Aug 7, 2026. Across all open-market trades the lifetime net is +$76.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $56.3M across reported positions. 44 SEC filings were submitted jointly with OPKO HEALTH, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$56.34M

Companies

14

Total Filings

143

Lifetime Open-Market Net

$76.6K

Filer Profile

Reported Address
OPKO HEALTH, INC.
4400 BISCAYNE BLVD.
MIAMI, FL 33137
Related Filers
OPKO HEALTH, INC. — 44 joint filings, latest 2026-07-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ENTX Director 34,117 $2.84 $96.9K $19.4K 4 2026-08-07
OPK Executive VP-Administration 26,663,028 $1.57 $41.86M $436.2K 40 2026-07-28
NAGE Director — $3.04 — $0 2 2026-06-26
ELOX Director — $15.75 — $0 7 2026-06-10
RDVT Director 147,767 $75.02 $11.09M -$389.3K 11 2026-06-05
COCP Director 2,660,242 $1.24 $3.30M $0 7 2026-01-13
Niagen Bioscience, Inc. (CDXC) Delisted Director 7,000 $7.87 $55.1K $10.2K 10 2024-06-24
Castle Brands Inc (ROX) Delisted Director 22,500 — — $0 11 2019-10-09
VBI Vaccines Inc/BC (VBIV) Delisted Director 1,875 $0.07 $122 $0 4 2018-06-18
BCDA Interim CEO and Interim CFO 187 $1.08 $202 $0 1 2016-08-12
Fluent, Inc. (IDI) Delisted Director 100,000 — — $0 5 2016-06-03
Fluent, Inc. (IDI.WS) Delisted Director — — — $0 1 2010-01-13
DREAMS INC (DRJ) Delisted Director — — — $0 3 2009-08-05
Ideation Acquisition Corp. (IDI.U) Delisted Secretary 157,500 — — $0 1 2007-11-28

Recent Filings

143 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-07 ENTX Grant (A) +19,117 $0 EDGAR
2026-08-07 ENTX Grant (A) +19,117 $0 EDGAR
2026-07-28 OPK Tax (F) −53,266 -$65.0K EDGAR
2026-06-26 NAGE Grant (A) — $0 EDGAR
2026-06-10 ELOX Grant (A) — $0 EDGAR
2026-06-05 RDVT Grant (A) +2,179 $0 EDGAR
2026-05-08 — Mixed +1,875 $0
2026-02-17 ENTX Buy (P) +5,000 $7.5K EDGAR
2026-02-11 ENTX Buy (P) +10,000 $12.0K EDGAR
2026-01-13 COCP Grant (A) — $0 EDGAR
Showing 1–10 of 143
Page 1 of 15
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.